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Abstract: Cytochrome P450, a family of monooxygenase
enzymes, is organized as a catalytic metabolon, and requires
enzymatic partners as well as environmental factors that tune
its complex dynamic activity. P450 and its reducing counter-
parts are membrane-bound proteins which are believed to
dynamically interact to form functional complexes. Increasing
experimental evidence signifies the role (s) of protein-lipid
interactions in P450’s catalytic function and efficiency. The
challenges posed by the membrane have severely limited
high-resolution understanding of the molecular interfaces of
these interactions. Nevertheless, recent NMR studies have
provided piercing insights into the dynamic structural
interactions that enable the function of P450. In this review,
we will discuss different biomimetic approaches relevant to
unveil molecular interplays at the membrane, focusing on our
recent work on lipid-nanodiscs. We also highlight the need to
expand the use of nanodiscs, and the power of a combination
of cutting-edge solution and solid-state NMR techniques, to
study the dynamic structures of P450 as well as other
membrane-proteins.
1. Introduction
Cytochrome P450 (P450) enzymes are a ubiquitous family of
monooxigenases responsible for the catalysis of numerous
reactions of both physiological and biotechnological impor-
tance.[1] They are widely diffused in the prokaryotic and
eukaryotic worlds, including plants, fungi and animals. In plants,
P450s are the key components in numerous processes of
general and specialized metabolism, including the biosynthesis
of plant hormones, and in cell wall biosynthesis as well as in
the biosynthesis of specialized compounds involved in plant
defense.[2] In mammalians, more than 40 gene families have
been recognized; similar to plants, mammalian P450s partic-
ipate in the biosynthesis of steroid hormones, and are pivotal in
cholesterol homeostasis and other signaling processes.[1] In
humans, 58 distinct P450s genes have been identified, and 13
isoforms are involved in the metabolism of drugs and xeno-
biotics,[3] consolidating P450’s research as major interest for
pharmacology, pharmacogenetics and drug discovery areas.
Eukaryotic P450s are membrane proteins, bound to the
membrane of the endoplasmic reticulum (ER) or mitochon-
dria,[4–5] whereas most bacterial P450s are soluble.[1] In humans,
the catalytic action of cytochrome P450s occurs via inter-
protein electron transfer (ET) between the oxygenase (P450)
and the reducing counterparts cytochrome P450-reductase
(CPR) or adrenodoxin reductase for ER or mitochondrial
systems, respectively. Both electron transferases are membrane-
associated proteins and use NADPH cofactor as reducing agent.
P450’s catalysis, including ligand binding and the electron-
transfer steps, is orchestrated at the membrane interface, giving
the lipid bilayer a vast importance that spans reaction efficiency,
protein stability as well as protein subcellular organization.[1,6–7]
At the same time, the lipid membrane poses numerous
challenges for both structural and kinetic studies.[6] Unlike the
intrinsic membrane proteins, the large-soluble domain contain-
ing P450 defies structural and physiologically-relevant func-
tional investigations. In this review, we aim to provide back-
ground and an overview of P450’s dynamics within the lipid
membrane and their consequences on its structure and activity.
We will discuss different biomimetic approaches relevant to
unveil molecular interplays at the membrane, focusing on our
recent work on peptide-based nanodiscs.[8] Lastly, a perspective
of the horizons of microsomal P450’s research will be discussed.
1.1. Structure and Function of Cytochrome P450
Cytochrome P450s are ~56 kDa proteins consisting of 12 a-
helices and anti-parallel b-sheets.[1] The N-terminus contains the
transmembrane domain (TMD), which includes a signal-anchor
sequence, a stretch of hydrophobic amino acids, followed by a
basic sequence and a proline-rich sequence.[9–10] The lower cleft
of the cytosolic domain is also believed to interact with the
membrane, through the so-called b-finger region and the FG
loop (Figure 1a). This extended protein/membrane interface
explains P450’s modest lateral membrane mobility, as observed
in both model[11–12] and cell membranes.[10] All P450s possess an
essential heme prosthetic group, stacked between the I and L
helices. The heme is bound to the protein skeleton via a
coordination of Fe-thiolate bound with the proximal cysteine
residue. The heme sits in a relatively large pocket, surrounded
by hydrophobic amino acid residues to accommodate hydro-
phobic substrates. The P450’s metabolic cycle proposed in 1966
by Omura and coworkers,[13] except for a few adjustments, is
still valid (Figure 1b). In the rest state, the oxidized Fe3 +-P450 is
mainly in low-spin electronic configuration; substrate binding
alters the spin state to high-spin, making the iron prone to be
reduced (Fe2 +-P450).
Fe2 +-P450 can then bind molecular oxygen and receive an
additional electron to form the unstable hydroperoxyl inter-
mediate known as Compound-0 (Cpd 0). The O22 :porphyrin
complex reacts with the surrounding protons to form the
catalytically active oxyferryl intermediate, known as Compound-I
(Cpd I). The Fe-ligated oxygen atom is then transferred to the
substrate, and the hydroxylated product is then released.
Beside hydroxylation, P450s also catalyze a variety of other
significant reactions, including O- and N-demethylation, and
epoxidation, although additional minor and unusual chemistries
have been reported.[15]
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Several aspects of P450’s catalytic cycle are entwined to the
lipid membrane.[6] P450s mostly catalyze reaction on lipophilic
compounds, thus ligands’ partition is likely shifted to the
hydrophobic core of the lipid membrane, rather than to the
cytosol. As a consequence, the migration of ligands towards
the active site occurs via protein “hydrophobic channels”
exposed to the membrane leaf, as pointed out by several
authors.[16–17] A few isoforms, including the major drug-metabo-
lizing CYP3 A4, possess an allosteric site facing the mem-
brane,[18] a finding that has a particular significance for drug-
drug interactions.[19–21] The catalytic function of cytochrome
P450s require two electrons: both electrons can directly be
transferred by CPR; or after the direct transfer of the first
electron by CPR, the second electron can be first transferred
from CPR to cytochrome b5 (cytb5) and then from cytb5 to P450.
The thermodynamic force driving the electron transfer is the
difference in redox potential between the donor (CPR or cytb5)
and the acceptor (P450) in their metabolically active forms. For
the redox couple CPR2:P450-Fe2 +, the redox potential differ-
ence is about 300 mV in the absence of a substrate.[22] Cytb5
has a higher redox potential (+ 25 mV), which makes it unable
to transfer the first electron to P450.[23] The ternary enzymatic
system is collectively known as “P450 metabolon”, since the
high interdependence between the different enzymes in
performing the catalysis.[7] CPR and cytb5 are also membrane-
anchored proteins, although their topology differs from that of
P450. CPR is a large (~78 kDa) flavoprotein with a flavin adenine
dinucleotide (FAD) and a flavin mononucleotide (FMN) domains
connected via a hinge region. CPR contains a highly disordered
region in the N-terminus preceding the helical transmembrane
domain; CPR’s high lateral mobility is probably related to its
different topology compared to P450.[11–12] Cytb5 is instead a
small (~15 kDa) hemeprotein, whose full-length membrane-
bound high-resolution structure and topology were determined
by our group using a combination of solution and solid-state
NMR techniques.[24] We revealed that, similar to P450, cytb5 is
indeed a bitopic membrane protein with a cytosolic domain
not interacting with the membrane surface, and exhibit fast
time scale of motion (~microsecond or faster).[25–26] Our solid-
state NMR experiments revealed that the transmembrane
domains of both cytb5 and P450 were found to be helical with
~158 tilt relative to the lipid bilayer normal, and undergo a very
slow time scale of motion (<milliseconds).[14,25] In addition, our
recent dynamic nuclear polarization (DNP) based magic angle
spinning (MAS) solid-state NMR experiments revealed that the
two transmembrane domains interact in the cytb5-P450 com-
plex and have a cross at the leucine zipper region of cytb5.
[14]
Our solution NMR experiments have revealed the interacting
interface in the soluble domains of the cytb5-P450 complex.
[24]
The interactions between P450 and the redox counterparts are
dynamic in nature,[12] and allow the respective prosthetic
moieties to be in a spatial vicinity suitable for ET to occur.
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Figure 1. Structure and function of cytochrome P450. a) Membrane topology
of cytochrome P450 (CYP2B4, PDB code is 1SUO). The transmembrane (TM)
domain was built in Chimera using the sequence retrieved in Uniprot
database. Based on oriented solid-state NMR experiments, the transmem-
brane domain spans the lipid bilayer and is tilted ~158 away from the lipid
bilayer normal (the angle is accentuated in the picture).[14] Residues of the
cytosolic domain also interact with the lipid bilayer. b) The catalytic cycle of
cytochrome P450. The binding of substrate RH (1) causes a decrease in the
redox potential of about 100 mV, which allows the first electron transfer
from cytochrome P450-reductase (CPR) (2). The reduction of Fe3 + to Fe2 + in
P450 enables O2 binding (3) and acceptance of a second electron from either
CPR or cytochrome b5 (cytb5) (4) to form a hydroperoxyl intermediate known
as Compound-0. The O22 complex reacts with surrounding protons to form
the highly reactive oxyferryl intermediate, also known as Compound-I (5). The
Fe-ligated O atom (6) is transferred to the substrate forming a hydroxylated
form of the substrate (ROH) (7). The product (ROH) is finally released (8) by
replacing it by a water molecule. Three uncoupling reactions are shown as
dashed lines, with the respective products: the autoxidation shunt ðO22 Þ, the
peroxide shunt (H2O2), and the oxidase shunt (H2O) (adapted from Barnaba
et al.[6]).
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2. Nanodiscs as a Platform for P450’s
Biophysics
2.1 Early Membrane Mimetics for P450’s Biochemical Studies
Since the dawn of P450’s research it was unequivocal that a
lipid-like environment was vital for both stability and activity of
cytochrome P450, in spite of studies that continue to avoid the
use of membrane due to the associated complexities. Pioneer-
ing studies by Ingelman-Sundberg and Coon established that a
lipid environment is essential for CPR-mediated ET and thus
cytochrome P450 catalysis, and protein/lipid interactions are
governed by the electrostatic nature of lipids.[27–29] Hence,
parallel to biochemical studies, a conspicuous effort has been
directed to develop membrane systems that could closely
mimic the native lipid bilayer. Detergent-based micellar systems
and liposomes have been broadly used for activity reconstitu-
tion, although our results and other groups have shown that in
detergent P450 exists in the inactive P420 state.[24] On the other
hand, bicelles exhibited native-like folding and function for
P450, and enabled high-resolution NMR studies.[30] Although
bicelles rendered far more stability for active P450, it was
limited to days. Since the detergent or short-chain lipid
molecules surrounding like a belt of the planar lipid bilayer in
bicelles diffuse into the lipid bilayer, our results showed that
P450’s stability directly depend on the amount of lipids to
detergent ratio. On the other hand, homogeneous[28] and
heterogeneous[31] liposomal preparation have shown good
metabolic activity performances compared to native micro-
somal extracts. Liposomes have also been extensively used for
spectroscopic studies on protein-protein interactions of the
metabolon.[6,32] It is worth mentioning that beside a few
examples,[33] the composition of liposomes did not take the
native membrane heterogeneity into account. The ER mem-
brane is highly heterogeneous: it is mainly composed by
zwitterionic phospholipids (75–85 %), with a discrete percent-
age of negatively charged components (10–15 %) including
phosphatidylserine (PS) and phosphatidylinositol (PI). Surpris-
ingly, a consistent body of literature has been sustained by
spectroscopic and kinetic studies performed on membrane
mimetics that are far to be representative of the ER membrane.
To cite a few examples, several studies have been realized on
highly-negatively charged baculovirus expression systems (also
known as baculosomes),[34] whose cell membrane contains up
to 23 % PI and 36 % PE.[35] Others[34,36] have used liposomal
preparations enriched with phosphatidic acid (PA), which is
known to segregate in large microdomains. Although useful for
metabolic and structural purposes, the authors consider that
the extrapolation of more profound biological considerations –
such as subcellular protein organization and protein-protein
dynamics – from reconstitution systems that are not represen-
tative of the ER membrane can be biased by artifact and should
be avoided. Only very recently such ambiguity has been finally
recognized, and protein-membrane and protein-protein dynam-
ics in the P450’s metabolon have been approached at both
ensemble and single-molecule level using mimetics closely
resembling the ER membrane.[11–12,37] High-resolution in-cell
solid-state NMR investigation was recently reported to probe
the structural features and membrane interaction of cytb5, and
demonstrated that the use of lipid vesicles provided near-native
results for the cytochrome protein.[38]
Removal of the transmembrane domain of cytochrome
P450 results in a solubilized form of the enzyme that – although
only marginally active – has been found to be suitable for
crystallization studies. For decades, it has been a useful strategy
and allowed the crystallization of several P450s, including 22
human isoforms.[39] On the other hand, full-length structural
studies of P450 have been overwhelming for many decades;
the structure of the yeast CYP51 in detergents by Monk et al.[40]
is the only full-length P450 X-ray structure to date, albeit the
lack of a lipid bilayer in the sample. Structural NMR is the
“trojan horse” that has allowed some of the most important
breakthroughs in P450’s research,[25,41–42] uncovering critical
information regarding both protein-protein and protein-mem-
brane information that were previously secluded. Our labora-
tory has led the use of both solution and solid-state NMR
techniques to study reconstituted P450, from the early works
on magnetically-aligned bicelles[43–44] to our more recent efforts
using sophisticated nanodiscs.[8,45–46] The information provided
by studies on full-length protein in native-like environments
have opened new opportunities and overcome challenges in
biochemical and pharmacological facets of P450’s research, and
concurrently abet novel questions related to the organization
of the metabolon in the cellular membrane.
2.2 From MSP to Peptide-based Lipid Nanodiscs
Nanodiscs are lipid bilayer patches surrounded by an amphi-
philic belt which takes inspiration from plasma lipoproteins.[47]
Since their introduction,[48–49] nanodiscs have imposed them-
selves as the “gold standard” for lipid membrane mimetic, for
both kinetic and structural studies.[47] Three generations of
nanodiscs have succeeded over time, with the major differences
being the surrounding belt. The membrane-scaffold protein
(MSP) nanodiscs were first introduced, being directly inspired
by plasma apolipoproteins (apoAI), which is the major protein
component of high-density lipoproteins. MSP and its derivatives
are large proteins (200–400 aa) that spontaneously form nano-
discs with several phospholipids; dimyristoylphosphatidylcho-
line (DMPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line (POPC) nanodiscs are the most used for structural studies.
However, the rigidity provided by such a long amino acid chain
makes obligate the co-presence of detergent (i. e. sodium
cholate) for facilitating protein reconstitution. Detergents are
then removed by dialysis and homogeneous nanodiscs prepa-
rations are generally attained.[47–49] Later on, it has been noticed
that mimetic of fragment (and designed) amphipathic peptides
of apoAI can also spontaneously self-assemble with lipids to
form nanodiscs, with the following advantages: i) the size of
nanodiscs is adjustable by varying the lipid:peptide molar ratio,
and ii) detergent is not required for protein reconstitution.
Among such peptides, we have successfully demonstrated that
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22 A and 4F can be used for P450’s metabolon reconstitution.[50]
22 A is derived from the repeated a-helix domain of apoAI but
it is not easy to form nanodiscs with varying lipid mixtures. 4F
was developed by Kariyazono et al.[51] and has been shown to
overcome some of the technical limitations of 22 A, including
high versatility in lipid composition and stability during the
size-exclusion chromatography steps necessary for nanodiscs’
purification.[45,52] We will discuss more about the peptide-based
nanodiscs in the next section. For the sake of completeness, it
is worth mentioning the polymer-based nanodiscs, which are
the third generation of these type of membrane mimetics. The
styrene-maleic acid (SMA) copolymer was the first efficiently
used to reconstitute membrane proteins.[53] Recently, our group
has synthesized other SMA-based polymers that are able to
form lipid nanodiscs (<20 nm diameter in size) that can be
used for solution NMR studies and macro-nanodiscs (>20 nm
diameter up to ~60 nm) that can magnetically-align and enable
solid-state NMR experiments.[54–56] These novel SMA derivatives
have been demonstrated to exhibit enhanced chemical and
physical stability (against temperature, pH, and divalent metal
ions such as Ca2 + and Mg2 +) compared to the original SMA.
Our group has also recently demonstrated the nanodiscs
formation by a new class of polymethacrylate copolymers, that
are “styrene-free” and can be used for fluorescence and circular
dichroism (CD) measurements. Therefore, these polymers can
be used for the investigation of membrane-assisted amyloid
aggregation and to trap transient toxic amyloid intermediates
for biomedical applications.[57]
3. P450-Lipid Interactions at Nanometric Scale
Dissecting the roles of lipids on P450’s function and stability
has occupied several research groups across the last decades.
An exhaustive scrutiny of those findings is beyond the scope of
this work and has been the subject of recent reviews.[6,58]
Instead, we will trace a route that goes from the initial
speculations on P450’s organization in the membrane towards
our recent findings[8] on the extraordinary ability of P450 in
modifying its surrounding lipid boundaries.
3.1 Lipids and P450: Old Tale, New Twists
Early quantitative measurements in rat microsomes revealed a
surprisingly unbalanced stoichiometry between P450 and CPR,
with P450 in 5-to-10 folds excess.[59] Thus, to explain CPR’s
efficiency in electron delivery, several speculations were made,
which can be summarized in two different theories. The first,
proposed by Estabrook[60] and adopted by others,[33,61] lied in
the supposed organization of P450’s monomer in quaternary
complexes or “clusters” served by the monomeric CPR. Another
theory developed in the same period attributed the observed
ET efficiency to the differences in protein lateral organization
and mobility.[62] This last model has been recently corroborated
by single-molecule microscopy studies on CYP2C9 and CPR
reconstituted in a ER biomimetic.[11–12] Diffusion models are
mainly sustained on protein mass transport and kinetics at the
membrane surface, making it more attractive while more
challenging in terms of experimental probing. More impor-
tantly, a “diffusion model” cannot omit the role played by the
lipid constituents, making it more appealing for membrane
biophysical investigation. As a matter of fact, after liposomes
were established as mimetic to reconstitute microsomal P450-
CPR pair activity by Ingelman-Sundberg and Coon,[27–29] Stier’s
group further explored the role of phospholipids in the
monooxygenase functions, even suggesting a “specific require-
ment” of phosphatidylcholine (PC) and phosphatidylethanol-
amine (PE) for P450 and CPR activities, respectively.[63–64] For
CPR, the reason of such a molecular preference resides in the
negative-curvature effect provided by PE that may help to
accommodate its relatively large cytosolic domain. Experiments
performed with 31P-NMR on P450 and CPR purified from
microsomal extracts showed residual PE and phosphatidylserine
(PS) strongly bound to the protein.[65–66] Since membrane
protein purification requires high amounts of detergents, it is
undoubtedly that those results can be biased by the type of
detergent used and the experimental procedure. Notwithstand-
ing, it is certain that a strong lipid-protein association can be
established through weak bonds between specific polar
residues and the lipid’s polar head group. Given the mounting
evidence that PS could benefit P450’s catalysis, Guengerich’s
lab set the ternary mixture DLPC : DOPC : DLPS (1 : 1 : 1 w/w/w) as
the “standard” recipe for P450’s activity reconstitution, at least
for drug metabolism studies.[31] The appearance of MSP-nano-
discs did not significantly motivate research on exploring the
effects of membrane composition, and most of the initial
studies were focused on the protein stability and function in
this novel mimetic. In fact, homogeneous DMPC and POPC
nanodiscs served as predominant scaffold for countless studies
on P450’s kinetics and structure, and to date are still broadly
used. It was until 2009 that Sligar’s lab included a discrete
amount of PS lipid in POPC MSP-nanodiscs to study the effect
of a negatively-charged phospholipid on the P450-CPR couple,
demonstrating a modulation of CPR redox potential that
favoured electron transfer and thus catalysis. More recently, it
has also been shown that the length of the lipid chain has a
significant action on P450’s thermal stability, but marginally on
substrate binding kinetics.[67] This is potentially due to a
different orientation and immersion of the protein in the
membrane, as already displayed by molecular dynamic simu-
lations for several P450’s isoforms, including the human drug
metabolizers CYP3 A4 and CYP2C9.[58,68]
3.2 Membrane, Spin-state, and Protein-Protein Interactions
Nanodiscs composed of a heterogeneous membrane composi-
tion are achievable with both MSP and peptide-based nano-
discs.[37] As mentioned above, peptide-based nanodiscs do not
require detergent for protein reconstitution, avoiding tedious
detergent removal steps and possible artefacts of reconstitu-
tion.[45,50,52] A solution of isotropic nanodiscs has been well
demonstrated to be suitable for high-resolution solution NMR
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based structural studies on embedded membrane proteins.[50]
We took advantage of these properties of peptide-based lipid-
nanodiscs by performing spectroscopic and structural studies
on microsomal cytochrome P450 2B4 (CYP2B4) in DMPC, POPC
and heterogeneous POPC:POPS nanodiscs at various
phospholipid molar ratios.[52] In all the considered lipid mixtures,
we were able to form homogeneous nanodiscs preparations,
that were able to monomerize CYP2B4 or cytb5, as well as the
protein-protein complex. Visible absorption spectroscopy on
reconstituted nanodiscs demonstrated that membrane hetero-
geneity alters the spin-state equilibrium of P450’s heme, an
unexpected result that goes alongside with the already known
effects of protein architecture, ligands and porphyrin elec-
tronics on spin multiplicity.[70]
In the rest state, heme spin’s population is shifted towards
low-spin (85–95 %); when in anionic POPS-enriched membrane,
a significant shift to high-spin state was observed (30 %), which
is linked to a higher redox potential. Addition of cytb5 is known
to further push the equilibrium to the high-spin state that is
favourable for catalysis.[71] Surprisingly, we found that phospho-
lipids boosted this conversion to the point that almost 100 %
conversion was obtained when cytb5 was added to P450 2B4
reconstituted in 4F-nanodiscs in the presence of a saturating
substrate (Figure 2a). The spectroscopic studies were well
supported by solution NMR experiments on cytb5 titrated with
CYP2B4. 2D 15N-1H HSQC-TROSY NMR spectra indicated a
stronger and extensive interaction of cytb5 with CYP2B4, which
was more pronounced when 20 % of POPS was present. Several
interacting residues were found, in both the lower and upper
clefts of cytb5. Simulations performed using HADDOCK
[72] were
used to build a putative structural model for the complex in
nanodiscs, which reveals a close vicinity of the hemes for an
efficient electron transfer (Figure 2b).
3.3 Lipid-Exchange Experiment
Inspired from the above-mentioned findings, but also from the
earlier and genuine observations in microsomal preparations,[28–
29,63,66] we decided to use nanodiscs as a “magnifying lens” for
studying P450:lipid interactions. As mentioned above, in
peptide-based nanodiscs in which the surrounding belt is made
up of several peptides, and the nanodiscs undergo constant
dynamic collisions between themselves. Specifically, lipids can
“diffuse” from one nanodiscs to the others, a process known as
“lipid exchange”.[73–75] While several factors can control the lipid
exchange process, the lipid exchange has been found to be fast
in peptide and polymer-based nanodiscs, whereas it is
extremely slow in MSP nanodiscs.[76] Mechanisms of lipid
exchange between nanodiscs involve both monomer diffusion
and fast collisional transfer. We were recently able to directly
observe this phenomenon in 4F-DMPC nanodiscs by using
high-speed AFM and 31P-NMR experiments.[75] Lipid-exchange
between nanodiscs and in general membrane biomimetics has
emerged out to be very important for its implications in the
equilibrium of small-molecules between lipoproteins (i. e. high-
density lipoproteins) and cell membranes, as well as for
potential applications in membrane protein crystallography.[74,77]
This mass transport equilibrium can be potentially altered by
small-molecules, peptide or protein that are able to specifically
interact with membrane components, which is the basis of our
experimental approach. 4F-peptides formed highly homoge-
neous nanodiscs when incubated with an ER lipid mixture that
closely mimicked the native membrane composition. The ER
membrane also contained the minor constituents sphingomye-
lin (SM, 7 %) and cholesterol (Ch, 4 %). We incubated CYP2B4
with excess nanodiscs and allowed the membrane insertion
and lipid-exchange to occur overnight at a temperature above
the Tm of the lipid mixture. We used ~8-nm nanodiscs
(Figure 3a), that roughly contain 35 to 40 lipids per leaf.[51] The
fraction of nanodiscs containing CYP2B4 was subsequently
purified by size-exclusion chromatography (Figure 3b) and
lipids quantified by 31P-NMR (phospholipids) or GC-MS (choles-
terol).
3.4 Formation of a Lipid Shell Surrounding P450
As summarized in Figure 3C, a significant change in
phospholipid composition in the fraction containing protein
was observed. CYP2B4 was able to trap SM and Ch, while
partially excluding PE. A high local concentration of SM and Ch
was associated with liquid-ordered (lo) regions of the lipid
membrane, or the so-called raft domains.[78] Literature regarding
the existence and the nature of lipid rafts has been con-
troversial, but more recent evidence point out that domains in
native cell membranes are smaller than previously found for
model membrane (<100 nm), and are driven by both lipid-lipid
and lipid-protein interactions.[79] Rafts play important roles in
cellular signalling and membrane trafficking, although visual-
ization and characterization of rafts in cells is still challenging.[79]
Our membrane model was shown to be homogeneous over a
Figure 2. High-resolution investigation of P450-REDOX partner interaction.
Functional reconstitution of the ~70-kDa CYP2B4-cytb5 complex in 4F-
peptide based lipid-nanodiscs. a) Titration of CYP2B4 with cytb5 in presence
of excess ligand (benzphetamine) led to quasi-complete transition from low-
to high-spin of the P450’s heme in both DMPC and POPC:POPS (8 : 2) bilayer.
b) Putative model of the CYP2B4:cytb5 complex in lipid membrane, as
obtained by HADDOCK simulation using experimental restraints from both
X-ray crystallography and solution NMR (adapted from Ravula et al.[52] and
Yamamoto et al.[14]; lipid bilayer from Tieleman et al.[69]).
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broad range of temperature,[11] and fluorescence correlation
spectroscopy (FCS) of 4F-ER nanodiscs showed analogue profile
than 4F-POPC when an ordering-sensitive dye was used.[8] This
strongly evocates a role of the protein itself in segregating SM
and Ch. Few authors have hypothesized that membrane
proteins can be encased in a “shell” of SM and Ch that can
mediate the coupling between the transmembrane domain
and the fluid lipid bilayer.[80–81] The lipid shell is regulated by
specific interactions between protein residues and phospholi-
pid’s polar head groups.[80] Backes’ work in rat microsomes
found both P450 and CPR associated to detergent-resistant
domains (DRM), which do not necessarily overlap with lo
regions, given the questionable specificity of detergent in
targeting specific phospholipids.[82] On the other hand, Ch has
been shown to inhibit CYP3 A4 activity,[83] although it is likely
that the rigidity conferred by the lo region can affect protein’s
lateral diffusion and thus interprotein electron transfer. Another
interesting finding is the partial depletion of PE, which is known
to negatively shape the membrane curvature, and it was shown
to facilitate membrane binding and enhance the activity of
human CYP3 A4,[84] but not rabbit CYP1 A2.[85] Likely, there is an
isoform-specificity in the observed lipid segregation that
deserves further investigation. The formation of a lo phase in a
nanodisc is also reflected in a significant reduction in its
diameter (Figure 3d). P450 is highly unstable outside the
membrane and has a spontaneous and well-known tendency
to aggregate to form non-specific oligomers.[28,64] Furthermore,
without any protectant agent like glycerol or detergents (i.e
cholate or CHAPS), P450 easily converts to the inactive form
(P420) in which the fifth coordination to the proximate cysteine
is irreversibly lost. However, within the nanodisc, the protein is
stable even at room temperature for a few days.[52] Thermal
stability of CYP2B4 is membrane-dependent, as demonstrated
by us and others.[67] The significant increase in both Tm and ~H
observed after lipid-exchange (Figure 3e) means that the
tertiary structure of P450 is altered in the lo region.
We speculate that the association of P450 with the lipid
shell can affect the conformation of the protein by the changes
in the orientations of lipid-interacting residues.[80] Similarly, fatty
acid unsaturation and hence chains “packing” of lipids seemed
to have analogue effect.[67] When in the lo region, the phase
transition is broader, probably indicating that the heme binding
pocket is more open compared to the initial ER membrane,
similar to what exerted by a substrate in CYP3 A4.[67,86] For P450,
a compound enters the active site and perturbs the heme’s
local electronic environment causing a shift of electronic
configuration of Fe from low-spin to high-spin, with a
consequent alteration of redox potential (from 300 to
225 mV).[22] We expected the lipid-assisted conformational
change to have consequences in ligand binding, since in the
general mechanism of binding an open form of the enzyme
binds the substrate, and in doing so it folds around the
substrate into a closed form.[87] Indeed, the equilibrium constant
for BHT (butylated hydroxytoluene) binding was altered by the
nature of the surrounding lipids. The affinity was increased
going from solution (13 mM) to ER (6 mM), while the lo region
further increased the affinity equilibrium (3 mM).[8] This is also
accompanied with a dramatic increase in the low-to-high spin
shift, which is a signature of differences in heme’s exposure to
solvent. Considering the importance of ligand binding on
defining catalytic specificity, this membrane-dependent behav-
iour has direct consequence on the pharmacokinetics of
lipophilic drugs, which represent a great majority of pharmaco-
phores in the market.[88]
3.5 P450’s Specific Sphingomyelin Binding Region
Cytochrome P450s is structurally fragile if not surrounded by a
lipid-like environment. This peculiarity has dampened structural
studies in membrane phase, but concurrently pushed research-
ers to use molecular dynamics simulations to shed light on
protein-lipid interactions.[16,58,68] We performed both all-atom
Figure 3. P450 preference for lipid-raft domains is revealed by peptide
nanodiscs. Lipid-exchange experiment in 4F-ER nanodiscs allows the
characterization of protein-induced “raft” formation. a) Schematic of the
lipid-exchange experiment in peptide-based nanodiscs. In the absence of
protein (left) the nanodiscs undergo phospholipid (PL) exchange via
collisional transfer mechanism. The presence of a membrane protein (right)
in a fraction of nanodiscs can perturb the mass equilibrium if the protein is
able to specifically “retain” lipid components by weak protein-lipid
interactions. b) Protein-containing nanodiscs can be purified by size-
exclusion chromatography. c) The amount of lipid and cholesterol is
estimated by 31P-NMR and GC-MS chromatography, showing an enrichment
of SM and Ch in CYP2B4-containing nanodiscs, with a depletion of PE. d)
After lipid exchange, the diameter of a reconstituted nanodisc is reduced,
indicating that the formation of a raft domain has consequences in the
lateral distribution of lipid components. e) Differential scanning calorimetry
of CYP2B4 in solution or in 4F-nanodiscs before and after lipid exchange
show an increased thermal stability of the protein (adapted from Barnaba
et al.[8]).
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(AA) and coarse-grained (CG) molecular dynamics simulations
on CYP2B4 embedded in POPC or ER membranes. For the ER
membrane, we use the original membrane composition, as well
as the one enriched with SM and Ch. Briefly, both the
transmembrane domain and the soluble domain presented
different backbone dynamics in the lipid systems, with the
protein being more restrained in the ER’s lo domain (Figure 4a).
Regions belonging to the proline-rich sequence and the b-
finger motif presented higher rigidity compared to that in
POPC, as from the RMS fluctuations, indicating a stronger
interaction with membrane components. As a matter of fact,
after 100 ns simulation, a few residues in the sequence
spanning the connecting loop (28Gly-Leu40) and the b-finger
(375Thr-Ile382) showed specific interactions with SM. Sequence
alignment performed on several microsomal P450s showed
that the membrane-interacting residues are conserved among
P450’s isoforms, which likely indicated that other P450s possess
similar ability to interact with lipids.
4. Potential of Nanodiscs to Study
Protein-Lipid Interactions
4.1 Current Strategies
Specific interactions between membrane-associated proteins
and membrane lipid components have captivated the attention
of researchers for decades.[89] Integral and membrane proteins
account for roughly one-third of the full proteome[89] and thus
protein-lipid interactions are of paramount interest in pharma-
ceutical discovery.[90] The complexity in terms of diversity and
size of membrane components makes a detailed and unambig-
uous characterization of the interactions of transmembrane
segments within a lipid bilayer highly challenging.[91–92] High-
resolution determination of molecular structure using diffrac-
tion methods requires high quality 3D crystals that are hard to
obtain for membrane proteins, although significant break-
through have been made by lipid-cubic phase crystallography
and cryo-EM techniques.[93–94]
On the other hand, fluorescence-based techniques allow to
visualize protein-lipid interaction in model membranes and
cells. Model membrane systems – planar supported bilayers[95–
96] and giant-unilamellar vesicles (GUVs),[97] among others – have
aided our understanding on the lipid organization of proteins
in cell membranes.[98] The advent of super-resolution imaging
has impacted the microscopy field by overcoming the
diffraction limit,[96] and so solving structure that are separated
by ~200 nm. However, a nanometric scale resolution is not
accessible with microscopy techniques. Another common draw-
back of fluorescence-based techniques is the need of fluores-
cent lipid probes for visualization, that are not equivalent to
their endogenous counterparts and can potentially create
artefacts.[98] Any attempt to understand physiological function
of membrane-associated proteins must also be as precise and
quantitative as possible. Along with the fact that extrapolating
structural insights from fluorescence microscopy is not feasible,
it is mandatory to develop new methodologies that can
overcome these limitations and concurrently capture protein-
membrane interfaces at nanoscale resolution.[89]
4.2 Opportunities from Peptide- and Polymer-Based
Nanodiscs
Detergent-free protein reconstitution and lipid-exchange dy-
namic are the major strengths of peptide or polymer-based
nanodiscs. The existence of a mass equilibrium among
individual nanodiscs make them prone for countless applica-
tions in structural biology and biophysics. We expect that our
lipid-exchange strategy can potentially help answering some of
the current questions in the biochemistry and biophysics of
membrane-associated proteins and peptides. From the P450’s
side, although the transmembrane region is highly conserved,
we cannot exclude an isoform-specific dependency on lipid-
protein interactions. This is a fascinating hypothesis, that goes
along with lipid signalling mechanisms that have been shown
to provide the metabolic flexibility of the endoplasmic
reticulum.[99] As a matter of fact, given the heterogeneity of the
P450’s metabolon in terms of substrate catalysis, we anticipate
that lipid-protein interactions could also play a role in the
catalytic sorting. The role played by membrane and local lipid
heterogeneity on P450’s structure complements the recent
finding on the conformational recognition triggered by sub-
strate and inhibitors binding.[12,100] The formation of electron
transfer binary and ternary complexes with CPR and cytb5 could
Figure 4. Membrane-bound structure of P450. Atomistic insights into the
interaction between CYP2B4 and the ER membrane. a) Coarse-grained
snapshot showing the TMD’s orientation in POPC (left) and ER (right)
nanodiscs at 0 (cyan) and 1 ms (orange). b) All-atom snapshot illustrating the
interaction between CYP2B4 and ER membrane when enriched with SM and
Ch. SM is shown in black. Specific residues are interacting with SM polar
group (insert). c) Percentage of helicity per residue in the TMD during
simulation time in different lipid systems. d) Root mean square fluctuations
of CYP2B4 in different lipid systems (adapted from Barnaba et al.[8]).
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also be driven by specific interaction between the trans-
membrane domains of the proteins and the surrounding lipids.
It is also known that the lipid membrane composition in the ER
and other subcellular compartments is modulated by several
physiological factors, including chronic disorders, inflammation
and ageing. More than three decades ago it was already
observed that an in vivo reduction of P450’s activity parallel to a
decline in the ratio of PC to PE and SM due to ageing.[101] A
similar consideration is valid for mitochondria and associated
monooxygenase system.[102] Thus, applications for lipid-nano-
discs and lipid/protein interaction can transcend the mere
interest in drug metabolism to a broader understanding of the
function of the membrane oxygenase systems across different
stages of life, in as much as during chronic pathologies. In fact,
several other biological processes are governed by specific
lipid-protein interactions, including amyloid aggregation,[103] the
insertion of pore-forming peptides,[104–105] and virus entry,[106]
among others. The lipid-exchange experiment coupled with
structural studies can potentially discern lipid-induced struc-
tural fluctuations that modulate such mechanisms.
5. Final Remarks
Earlier research in microsomal oxygenase systems had a
genuine interest in protein-lipid interactions, which was un-
fortunately underestimated in the following decades.[6] Some of
the important discoveries of the last decade in P450 related
research have foundations on those pioneering observations.
Indeed, as from the Proceedings of the 3rd International
Symposium in Microsomes and Drug Oxidation in 1977, Stier
and coworkers already noticed a rigid lipid area surrounding
P450, with a partial depletion of PE and enrichment of SM.[107]
Forty-years later, those cautious speculations were ultimately
and quantitatively demonstrated by our group using sophisti-
cated tools. The last decade has seen a progressive interest on
the role played by membrane in the catalysis of P450s, as many
studies and reviews have been published. Nanodiscs have
certainly boosted the experimental capabilities, although the
technical improvements of structural techniques – in particular
solution and solid-state NMR – and their applications to
functional membrane systems cannot be ignored. Particularly,
the use of peptide or polymer based nanodiscs (and the
weakly-aligned macro-nanodiscs) for solution NMR and the
unique magnetically-aligned macro-nanodiscs for solid-state
NMR experiments bound to expand the power of NMR
applications to study a large range of membrane proteins and
membrane-bound protein-protein complexes. While the sophis-
ticated DNP experiments can be used to overcome the
challenges faced by the poor sensitivity, the rapidly advancing
proton-detected and ultrafast-MAS techniques will also be
valuable to obtain high-resolution insights into protein-protein
and protein-substrate interactions.[108–121] We also expect the
macro-nanodiscs to be highly valuable for studies using cryoEM
and diffraction experiments. We hope that more researchers
will be attracted by the unanswered fundamental questions to
fully understand the organization and function of membrane-
bound P450s.
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